Mediterranean Diet Plus Extravirgin Olive Oil in the Prevention of Recurrent Arrhythmias. The PREDIMAR (PREvención Con DIeta Mediterránea de Arritmias Recurrentes) Trial
NCT03053843 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 720
Last updated 2020-04-09
Summary
Background: Atrial fibrillation (AF) is the most frequent cardiac arrhythmia and represents a high priority public health problem, as in a few decades it will become a possibly unsustainable load for the national health system. Preventive and therapeutic strategies based on the best possible scientific evidence are required. Ablation therapy, despite being the most effective approach, is associated with a 30-35% arrhythmic recurrence rate. An intervention with Mediterranean diet and extra virgin olive oil (EVOO) has proven effective in primary prevention and reduced the incidence of AF in high-risk subjects in a recent, large, randomized trial (PREDIMED).
Methods: Parallel, randomized, multicenter nutritional intervention trial in 640 patients with AF treated with catheter ablation. Two groups will be randomized in a 1:1 ratio: 1) intervention with Mediterranean diet and EVOO; 2) usual care (control group). The primary objective will be the incidence of atrial tachyarrhythmias for two years after ablation. At least 190 recurrences are expected after 2 years (median) of follow-up. A relative risk of 0.7 is assumed and statistical power of 80%. Follow-up visits will be scheduled at 3, 6, 12, 18 and 24 months. In addition to the in-person visits, event monitors will be used to document episodes. Dietary intervention will be carried out by nutritionists who will use methods adapted from the PREDIMED trial with contacts every 2 months. 1 liter of EVOO per week will be provided for free in the intervention arm. Inflammatory markers will be analyzed in both groups during follow-up. Cox models will be used to estimate adjusted hazard ratios.
Conditions
- Atrial Fibrillation
- Atrial Arrhythmia
Interventions
- DIETARY_SUPPLEMENT
-
Mediterranean diet plus extra virgin olive oil
The patients in the intervention group will receive 1 liter of EVOO per week free of charge and dietary advice on how to follow a Mediterranean diet with contacts every two months. Dietary intervention will be carried out by nutritionists with previous experience in the PREDIMED study. All of them were registered, trained and certified for developing the PREDIMED intervention protocol that is similar to the one to be carried out in this study. The theoretical sessions with patients about dietary education shall be conducted in telephone form, using the internet and sending comprehensive written material to their homes that includes recipes, shopping lists, menus and explanations of typical food in the Mediterranean diet
Sponsors & Collaborators
-
University of Navarra
collaborator OTHER -
University Hospital Virgen de las Nieves
collaborator OTHER -
Hospital General Universitario de Alicante
collaborator OTHER -
Fundación de investigación HM
lead OTHER
Principal Investigators
-
Miguel A Martinez González, MD, PhD, MPH · University of Navarra
-
Jesus Almendral Garrote, MD, PhD, FESC · Fundación HM
-
Teresa Barrio Lopez, MD, PhD · Fundación HM
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-22
- Primary Completion
- 2020-01-31
- Completion
- 2022-01-31
Countries
- Spain
Study Locations
More Related Trials
-
Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke.
NCT02180542 ·Status: COMPLETED
-
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT02208102 ·Status: COMPLETED
-
Early Recurrences of Atrial Arrhythmias and Their Impact on Late Recurrence After Pulmonary Vein Isolation With Pulsed Field Ablation of Paroxysmal Atrial Fibrillation
NCT05328882 ·Status: RECRUITING
-
A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation
NCT02789358 ·Status: COMPLETED ·Phase: NA
-
Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial
NCT03646643 ·Status: COMPLETED ·Phase: NA
-
NURSE-led Follow-up in Patients Undergoing CATheter Ablation for Atrial Fibrillation
NCT05333445 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
NCT05638841 ·Status: RECRUITING
-
Catheter Ablation of All Inducible AT Post AF Ablation
NCT03343860 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Characterization on Paroxysmal and Persistent Patients
NCT05343923 ·Status: COMPLETED
-
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
NCT01803438 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial Fibrillation
NCT01558635 ·Status: TERMINATED ·Phase: NA
-
Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care (AtrialConnect)
NCT05893199 ·Status: UNKNOWN ·Phase: NA
-
Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
NCT02839304 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation
NCT00523978 ·Status: COMPLETED ·Phase: PHASE3
-
Does Cardiac Rehabilitation Reduce the Risk of Recurrence of Atrial Fibrillation Following the First Catheter Ablation?
NCT03389633 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Early Detection of Atrial Fibrillation
NCT01291953 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
NCT04160000 ·Status: RECRUITING ·Phase: PHASE4
-
Internet-delivered Cognitive Behavior Therapy for Atrial Fibrillation
NCT03378349 ·Status: COMPLETED ·Phase: NA
-
Electrophysiological Effects of NACOS and AVK on Pulmonary Veins and Left Atrium in Paroxysmal AF Catheter Ablation
NCT02814955 ·Status: UNKNOWN
-
Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study
NCT02074566 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Prediction Trial.
NCT02307032 ·Status: UNKNOWN
-
Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins
NCT00321802 ·Status: COMPLETED ·Phase: PHASE2
-
Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
NCT02393885 ·Status: COMPLETED ·Phase: NA
-
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
NCT06354777 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of the Autonomic Nervous System on the Outcomes of PULSEd Field Ablation to Treat Atrial Fibrillation
NCT06351553 ·Status: NOT_YET_RECRUITING ·Phase: NA